Knight Therapeutics Inc. (TSX:GUD)
5.62
0.00 (0.00%)
Feb 21, 2025, 4:00 PM EST
Knight Therapeutics Employees
Knight Therapeutics had 725 employees as of December 31, 2023. The number of employees increased by 27 or 3.87% compared to the previous year.
Employees
725
Change (1Y)
27
Growth (1Y)
3.87%
Revenue / Employee
480.88K CAD
Profits / Employee
-42.38K CAD
Market Cap
563.65M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Green Thumb Industries | 4,561 |
dentalcorp Holdings | 9,900 |
WELL Health Technologies | 1,507 |
Curaleaf Holdings | 5,650 |
Sienna Senior Living | 12,263 |
Trulieve Cannabis | 5,400 |
Cronos Group | 356 |
Extendicare | 23,000 |
Knight Therapeutics News
- 25 days ago - Knight Therapeutics and Helsinn Healthcare SA Expand Relationship and Enter into Exclusive License, Distribution, and Supply Agreement for Onicit® - GlobeNewsWire
- 2 months ago - Knight Therapeutics Announces Regulatory Approval of TAVALISSE® in Mexico - GlobeNewsWire
- 2 months ago - Andrey Omelchak's Past Pick: Lumine, Trisura Group and Knight Therapeutics - BNN Bloomberg
- 3 months ago - Knight Therapeutics Inc. (KHTRF) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Knight Therapeutics Reports Third Quarter 2024 - GlobeNewsWire
- 4 months ago - Notice of Knight Therapeutics’ Third Quarter 2024 Results Conference Call - Financial Post
- 4 months ago - Notice of Knight Therapeutics' Third Quarter 2024 Results Conference Call - GlobeNewsWire
- 5 months ago - Knight Therapeutics Inc. places No. 397 on The Globe and Mail’s sixth annual ranking of Canada’s Top Growing Companies - Financial Post